You are here
Publications
Popular Publications
Fundamental Review of the National Efficient Price
3 December 2019The Fundamental Review of the National Efficient Price (NEP) was commissioned by IHPA to review the methodology underpinning the National Pricing Model. IHPA engaged Ernst & Young (EY), KPMG and PricewaterhouseCoopers (PwC) to independently perform the review in close consultation with IHPA’s advisory committees.
Management of Confidential Jurisdictional Information Protocol
8 July 2019The purpose of the Management of Confidential Jurisdictional Information Protocol is to advise jurisdictions of the processes and controls adopted by IHPA in managing confidential jurisdictional information as part of its rolling Three Year Data Plan.
IHPA Work Program 2019–20
27 June 2019As prescribed in Section 225 of the National Health Reform Act 2011, the objectives of the IHPA Work Program are to:
Non-admitted care costing study - data collection
17 April 2019The Independent Hospital Pricing Authority (IHPA) is currently developing a new classification for non-admitted care - the Australian Non-Admitted Care Classification (ANACC) - in response to the recommendations of public consultations in 2013 and 2014 on non-admitted care classification.
National Efficient Price Determination 2019-20
5 March 2019The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of Section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price (NEP) Determination 2019-20 (Determination):
National Efficient Cost Determination 2019-20
5 March 2019The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2019-20 National Efficient Cost Determination (Determination):
Non-admitted and Subacute Costing Study
8 December 2015Non-admitted study
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
Home Delivered Dialysis Services Costing Study Report
11 November 2014The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
Review and Costing Study into Radiotherapy Services
30 September 2014PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.
National Efficient Cost Determination 2014-15
28 February 2014The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2014-15 National Efficient Cost Determination (Determination):
(a) to determine the national efficient cost for health care services provided by public hospitals where the services are block funded;
National Efficient Price Determination 2014-15
28 February 2014The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2014 (Determination):
(a) to determine the national efficient price for health care services provided by public hospitals where the services are funded on an activity basis;
National Efficient Price Determination 2013-14
29 March 2013The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2013 (Determination):
(a) to determine the national efficient price for health care services provided by public hospitals where the services are funded on an activity basis;
National Efficient Cost Determination 2013-14
28 February 2013The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2013 (Determination):
(a) to determine the national efficient cost for health care services provided by public hospitals where the services are block funded;
National Efficient Price Determination 2012-13
30 May 2012The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2012-2013 (Determination):
(a) to determine the national efficient price for health care services provided by public hospitals where the services are funded on an activity basis;
